Forte Biosciences, Inc. (FBRX)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Forte Biosciences, Inc. (FBRX)
Company Performance

Current Price

as of Oct 16, 2024

$4.67

P/E Ratio

N/A

Market Cap

$6.82M

Description

Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. The firm's lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner in 2017 and is headquartered in Dallas, TX.

Metrics

Overview

  • HQDallas, TX
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerFBRX
  • Price$4.67+1.19%

Trading Information

  • Market Cap$6.82M
  • Float88.92%
  • Average Daily Volume (1m)11,475
  • Average Daily Volume (3m)71,095
  • EPS-$21.42

Company

  • RevenueN/A
  • Rev Growth (1yr)N/A
  • Net Income-$12.51M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$12.81M
  • EV$0.27M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/B0.40
Documents